Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality; D005500:Follow-Up Studies; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D020913:Perindopril / Q000627:therapeutic use*; D017257:Ramipril / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012107:Research Design; D020521:Stroke / Q000517:prevention & control; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D017257:Ramipril; D020913:Perindopril